B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from Patients

B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from Patients

The impact of the COVID-19 pandemic caused by the SARS-CoV-2 virus underscored the crucial role of laboratorial tests as a strategy to control the disease, mainly to indicate the presence of specific antibodies in human samples from infected patients. Therefore, suitable recombinant antigens are rel...

Full description

Bibliographic Details
Main Authors: Fernanda F. Ramos, Isabela A. G. Pereira, Mariana M. Cardoso, Raquel S. Bandeira, Daniela P. Lage, Rahisa Scussel, Rafaela S. Anastacio, Victor G. Freire, Marina F. N. Melo, Joao A. Oliveira-da-Silva, Vivian T. Martins, Grasiele S. V. Tavares, Danniele L. Vale, Camila S. Freitas, Ana Thereza Chaves, Júlia F. M. Caporali, Paula F. Vassallo, Cecilia G. Ravetti, Vandack Nobre, Flavio G. Fonseca, Myron Christodoulides, Ricardo A. Machado-de-Ávila, Eduardo A. F. Coelho, Fernanda Ludolf
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Viruses
Subjects:
B-cell epitopes
chimeric protein
diagnosis
urine
serum
SARS-CoV-2
Online Access:https://www.mdpi.com/1999-4915/15/9/1877

Internet

https://www.mdpi.com/1999-4915/15/9/1877

Similar Items